Ashley Kieran Clift
- Neurology top 5%
- Neuroblastoma Research and Treatments 15
- Oncology top 5%
- Lung Cancer Research Studies 21
- Pancreatic and Hepatic Oncology Research 6
- Global Cancer Incidence and Screening 3
- Epidemiology top 5%
- Neuroendocrine Tumor Research Advances 28
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 4
- Gastroenterology top 10%
- Gastrointestinal Tumor Research and Treatment 4
-
- COVID-19 and Mental Health 3
- Co-authors
- Andrea FrillingJulia Hippisley–CoxCarol CouplandPui San TanPaul AveyardNicola LindsonHarpreet WasanPeter Watkinson
- Cited by
- NeurologyOncologyEpidemiology
- Journals
- Annals of Internal Medicine (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)Cancer (1 paper)
- Partner nations
- United KingdomUnited StatesPoland
In The Last Decade
Ashley Kieran Clift
50 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Neurology 426
- Oncology 579
- Epidemiology 598
- Infectious Diseases 199
- Gastroenterology 45
Countries citing papers authored by Ashley Kieran Clift
This map shows the geographic impact of Ashley Kieran Clift's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Kieran Clift with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Kieran Clift more than expected).
Fields of papers citing papers by Ashley Kieran Clift
This network shows the impact of papers produced by Ashley Kieran Clift. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Kieran Clift. The network helps show where Ashley Kieran Clift may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ashley Kieran Clift, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 32 | |
| 9 | 2022 | 19 | |
| 10 | 2021 | 3 | |
| 11 | 2021 | 5 | |
| 12 | 2021 | 10 | |
| 13 | 2021 | 20 | |
| 14 | 2021 | 3 | |
| 15 | 2021 | 110 | |
| 16 | 2020 | 1 | |
| 17 | 2020 | 1 | |
| 18 | 2017 | 70 | |
| 19 | 2017 | 42 | |
| 20 | 2015 | 26 |
About Ashley Kieran Clift
Ashley Kieran Clift is a scholar working on Neurology, Oncology and Epidemiology, having authored 53 papers that have together received 1.2k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (28 papers), Lung Cancer Research Studies (21 papers), Neuroblastoma Research and Treatments (15 papers), Pancreatic and Hepatic Oncology Research (6 papers), COVID-19 Clinical Research Studies (4 papers), Gastrointestinal Tumor Research and Treatment (4 papers), COVID-19 and Mental Health (3 papers) and Global Cancer Incidence and Screening (3 papers). The work is most often cited by research in Neurology (426 citations), Oncology (579 citations) and Epidemiology (598 citations). Ashley Kieran Clift has collaborated with scholars based in United Kingdom, United States and Poland. Frequent co-authors include Andrea Frilling, Julia Hippisley–Cox, Carol Coupland, Pui San Tan, Paul Aveyard, Nicola Lindson, Harpreet Wasan, Peter Watkinson, Valérie Vilgrain and Maxime Ronot. Their work appears in journals such as Annals of Internal Medicine, The Journal of Clinical Endocrinology & Metabolism and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.